Literature DB >> 12010982

Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts.

Muzaffar Hussain1, Axana Haggar, Christine Heilmann, Georg Peters, Jan-Ingmar Flock, Mathias Herrmann.   

Abstract

To initiate invasive infection, Staphylococcus aureus must adhere to host substrates, such as the extracellular matrix or eukaryotic cells, by virtue of different surface proteins (adhesins). Recently, we identified a 60-kDa cell-secreted extracellular adherence protein (Eap) of S. aureus strain Newman with broad-spectrum binding characteristics (M. Palma, A. Haggar, and J. I. Flock, J. Bacteriol. 181:2840-2845, 1999), and we have molecularly confirmed Eap to be an analogue of the previously identified major histocompatibility complex class II analog protein (Map) (M. Hussain, K. Becker, C. von Eiff, G. Peter, and M. Herrmann, Clin. Diagn. Lab. Immunol. 8:1281-1286, 2001). Previous analyses of the Eap/Map function performed with purified protein did not allow dissection of its precise role in the complex situation of the staphylococcal whole cell presenting several secreted and wall-bound adhesins. Therefore, the role of Eap was investigated by constructing a stable eap::ermB deletion in strain Newman and by complementation of the mutant. Patterns of extracted cell surface proteins analyzed both by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by Western ligand assays with various adhesive matrix molecules clearly confirmed the absence of Eap in the mutant. However, binding and adhesion tests using whole staphylococcal cells demonstrated that both the parent and mutant strains bound equally well to fibronectin- and fibrinogen-coated surfaces, possibly due to their recognition by other staphylococcal adhesins. Furthermore, Eap mediated staphylococcal agglutination of both wild-type and mutant cells. In contrast, the mutant adhered to a significantly lesser extent to cultured fibroblasts (P < 0.001) than did the wild type, while adherence was restorable upon complementation. Furthermore, adherence to both epithelial cells (P < 0.05) and fibroblasts (not significant) could be blocked with antibodies against Eap, whereas preimmune serum was not active. In conclusion, Eap may contribute to pathogenicity by promoting adhesion of whole staphylococcal cells to complex eukaryotic substrates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010982      PMCID: PMC128007          DOI: 10.1128/IAI.70.6.2933-2940.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells.

Authors:  D Joh; E R Wann; B Kreikemeyer; P Speziale; M Höök
Journal:  Matrix Biol       Date:  1999-06       Impact factor: 11.583

2.  Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1.

Authors:  B Sinha; P P François; O Nüsse; M Foti; O M Hartford; P Vaudaux; T J Foster; D P Lew; M Herrmann; K H Krause
Journal:  Cell Microbiol       Date:  1999-09       Impact factor: 3.715

3.  Analogs of Eap protein are conserved and prevalent in clinical Staphylococcus aureus isolates.

Authors:  M Hussain; K Becker; C von Eiff; G Peters; M Herrmann
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Rebinding of extracellular adherence protein Eap to Staphylococcus aureus can occur through a surface-bound neutral phosphatase.

Authors:  M Flock; J I Flock
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

Review 6.  Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections.

Authors:  J I Flock
Journal:  Mol Med Today       Date:  1999-12

7.  Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells.

Authors:  B Sinha; P Francois; Y A Que; M Hussain; C Heilmann; P Moreillon; D Lew; K H Krause; G Peters; M Herrmann
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins.

Authors:  T Fowler; E R Wann; D Joh; S Johansson; T J Foster; M Höök
Journal:  Eur J Cell Biol       Date:  2000-10       Impact factor: 4.492

9.  Staphylococcal fibronectin binding protein interacts with heat shock protein 60 and integrins: role in internalization by epithelial cells.

Authors:  K Dziewanowska; A R Carson; J M Patti; C F Deobald; K W Bayles; G A Bohach
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Two restriction and modification systems in Staphylococcus aureus NCTC8325.

Authors:  S Iordanescu; M Surdeanu
Journal:  J Gen Microbiol       Date:  1976-10
View more
  30 in total

1.  The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells.

Authors:  Axana Haggar; Cecilia Ehrnfelt; Jan Holgersson; Jan-Ingmar Flock
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin.

Authors:  Christine Heilmann; Jörg Hartleib; Muzaffar S Hussain; Georg Peters
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution.

Authors:  Michal Hammel; Daniel Nemecek; J Andrew Keightley; George J Thomas; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

Review 4.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

5.  Heparin stimulates Staphylococcus aureus biofilm formation.

Authors:  Robert M Q Shanks; Niles P Donegan; Martha L Graber; Sarah E Buckingham; Michael E Zegans; Ambrose L Cheung; George A O'Toole
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

Authors:  Zvjezdana Sever-Chroneos; Agnieszka Krupa; Jeremy Davis; Misbah Hasan; Ching-Hui Yang; Jacek Szeliga; Mathias Herrmann; Muzafar Hussain; Brian V Geisbrecht; Lester Kobzik; Zissis C Chroneos
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

7.  The impact of CodY on virulence determinant production in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Frances E Rivera; Halie K Miller; Stacey L Kolar; Stanley M Stevens; Lindsey N Shaw
Journal:  Proteomics       Date:  2011-12-20       Impact factor: 3.984

8.  An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth.

Authors:  Fang Teng; Magdalena Kawalec; George M Weinstock; Waleria Hryniewicz; Barbara E Murray
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  A point mutation in the sensor histidine kinase SaeS of Staphylococcus aureus strain Newman alters the response to biocide exposure.

Authors:  Daniel Schäfer; Thiên-Trí Lâm; Tobias Geiger; Markus Mainiero; Susanne Engelmann; Muzaffar Hussain; Armin Bosserhoff; Matthias Frosch; Markus Bischoff; Christiane Wolz; Joachim Reidl; Bhanu Sinha
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

10.  eap Gene as novel target for specific identification of Staphylococcus aureus.

Authors:  Muzaffar Hussain; Christof von Eiff; Bhanu Sinha; Insa Joost; Mathias Herrmann; Georg Peters; Karsten Becker
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.